Overview

Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate whether preoperative TAC is able to improve progression free survival and overall survival in patients receiving liver metastasis resection of colorectal cancer.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Fudan University
Treatments:
Fluorouracil
Leucovorin
Oxaliplatin
Criteria
Inclusion Criteria:

- age <= 75 years

- resectable liver metastasis

- remnant liver volume >= 70%

- without other organ metastasis or peritoneum metastasis

- without contradiction of cardiac and pulmonary diseases

Exclusion Criteria:

- age > 75 years

- unresectable liver metastasis

- remnant liver volume < 50%

- with other organ metastasis or peritoneum metastasis

- with contradiction of cardiac and pulmonary diseases